Toxicity of antibacterial agents: mechanism of action on mammalian cells.
D000617:Aminoglycosides / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects*; D050260:Carbohydrate Metabolism; D002477:Cells / Q000187:drug effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003523:Cycloserine / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology; D004734:Energy Metabolism / Q000187:drug effects; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006311:Hearing Disorders / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced; D009422:Nervous System Diseases / Q000139:chemically induced; D009469:Neuromuscular Junction / Q000187:drug effects; D010716:Phosphatidylinositols / Q000378:metabolism; D011113:Polymyxins / Q000009:adverse effects; D013754:Tetracyclines / Q000009:adverse effects
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D010716:Phosphatidylinositols; D011113:Polymyxins; D013754:Tetracyclines; D003523:Cycloserine; D007538:Isoniazid